Abstract
A novel series of dual PPARα/γ agonists was designed through the modification of our previously described family of 8-HETE analogs. The combination of the structural elements of this family and of the classical PPAR ligands produced compounds with a quinoxaline core and two sides chains. Structure-activity relationship studies have been carried out on the new series and compounds belonging to this new family have been tested in vitro on both subtypes of PPAR nuclear receptors. Corresponding results indicated a strong decrease in the activity towards both subtypes, especially on PPARγ. However, they have also clearly shown the central role of the bottom side chain in the activity.
Keywords: PPARs, Diabetes, 8-HETE Analogs, Quinoxaline
Letters in Drug Design & Discovery
Title: Synthesis of a Novel Series of 8-HETE Analogs and their Biological Evaluation Towards the PPAR Nuclear Receptors
Volume: 5 Issue: 8
Author(s): Melanie Liutkus, Catherine Dacquet, Valerie Audinot-Bouchez, Jean Boutin, Daniel-Henri Caignard, Alain Ktorza and Rene Gree
Affiliation:
Keywords: PPARs, Diabetes, 8-HETE Analogs, Quinoxaline
Abstract: A novel series of dual PPARα/γ agonists was designed through the modification of our previously described family of 8-HETE analogs. The combination of the structural elements of this family and of the classical PPAR ligands produced compounds with a quinoxaline core and two sides chains. Structure-activity relationship studies have been carried out on the new series and compounds belonging to this new family have been tested in vitro on both subtypes of PPAR nuclear receptors. Corresponding results indicated a strong decrease in the activity towards both subtypes, especially on PPARγ. However, they have also clearly shown the central role of the bottom side chain in the activity.
Export Options
About this article
Cite this article as:
Liutkus Melanie, Dacquet Catherine, Audinot-Bouchez Valerie, Boutin Jean, Caignard Daniel-Henri, Ktorza Alain and Gree Rene, Synthesis of a Novel Series of 8-HETE Analogs and their Biological Evaluation Towards the PPAR Nuclear Receptors, Letters in Drug Design & Discovery 2008; 5 (8) . https://dx.doi.org/10.2174/157018008786898572
DOI https://dx.doi.org/10.2174/157018008786898572 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Early Biomarkers for Severe Drug Hypersensitivity Reactions
Current Pharmaceutical Design A Systems Biology Perspective on Rational Design of Peptide Vaccine Against Virus Infections
Current Topics in Medicinal Chemistry Cardiovascular Effects of Hypoglycemic Agents in Diabetes Mellitus
Current Drug Safety Targeting IAPs as An Approach to Anti-Cancer Therapy
Current Topics in Medicinal Chemistry Salusins in Hypertension and Related Cardiovascular Diseases
Current Drug Metabolism Bright Light Delights: Effects of Daily Light Exposure on Emotions, Restactivity Cycles, Sleep and Melatonin Secretion in Severely Demented Patients
Current Alzheimer Research The HIV Entry Inhibitors Revisited
Current Medicinal Chemistry Targeting Matrix Metalloproteinases in Acute Inflammatory Shock Syndromes
Combinatorial Chemistry & High Throughput Screening Histone Deacetylase Inhibitors Target Diabetes via Chromatin Remodeling or as Chemical Chaperones?
Current Diabetes Reviews A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates
Current Gene Therapy Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia
Current Cancer Drug Targets Optimising the Use of Non-Invasive Ventilation in the Intensive Care Setting
Current Respiratory Medicine Reviews Update on MDS Therapy: From Famine to Feast
Cardiovascular & Hematological Agents in Medicinal Chemistry Approaches to Optimize Gene Therapy for the Treatment of Hematologic Malignancies: Overcoming the Obstacles
Current Gene Therapy Molecular Targets and Abdominal Aortic Aneurysms
Recent Patents on Cardiovascular Drug Discovery N-Aryl-5-aminopyrazole: A Versatile Architecture in Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry Biological Predictors of Aging and Potential of FTIR to Study Age-related Diseases and Aging Metabolic Fingerprint
Current Metabolomics Recent Patents on Biomedical Applications for the Treatment of Atherosclerosis
Recent Patents on Regenerative Medicine Aging and DNA Methylation
Current Chemical Biology Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design